Neoantigenics
Charlottesville
About Neoantigenics
Neoantigenics is a liability company that focuses on developing oncology theranostics. These neoantigens are uniquely expressed in a wide range of urogenital tract cancers – ovarian, uterine, bladder, and renal cancers – as well as certain other solid cancers such as aggressive stages of pancreatic cancer and many head-and-neck cancers. It was founded in 2012 and headquartered in Charlottesville, Virginia.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.5M
- Funding stage: Seed
- Last round: Seed (Jan 2015)
- Website: neoantigenics.com
- Phone: 434-984-9723
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Oncology
Social Profiles
Canonical: https://fsome.com/organization/neoantigenics-2791542 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.